ZOGENIX INC's gross profit margin for the second quarter of its fiscal year 2015 has significantly decreased when compared to the same period a year ago. The company managed to grow both sales and net income at a faster pace than the average competitor in its industry this quarter as compared to the same quarter a year ago. ZOGENIX INC is extremely liquid. Currently, the Quick Ratio is 2.63 which clearly shows the ability to cover any short-term cash needs. The company's liquidity has increased from the same period last year.
At the same time, stockholders' equity ("net worth") has greatly increased by 58.20% from the same quarter last year. Overall, the key liquidity measurements indicate that the company is very unlikely to face financial difficulties in the near future.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.
|Income Statement||Q2 FY15||Q2 FY14|
|Net Sales ($mil)||7.37||6.74|
|Net Income ($mil)||72.46||62.87|
|Balance Sheet||Q2 FY15||Q2 FY14|
|Cash & Equiv. ($mil)||96.43||89.74|
|Total Assets ($mil)||246.7||133.3|
|Total Debt ($mil)||22.04||2.29|
|Profitability||Q2 FY15||Q2 FY14|
|Gross Profit Margin||25.98||46.25|
|Return on Assets||6.58||-3.4|
|Return on Equity||-46.45||38.22|
|Debt||Q2 FY15||Q2 FY14|
|Share Data||Q2 FY15||Q2 FY14|
|Shares outstanding (mil)||19.18||17.63|
|Div / share||0.0||0.0|
|Book value / share||5.64||3.88|
|Institutional Own %||n/a||n/a|
|Avg Daily Volume||1521333.0||3217074.0|
SELL. This stock’s P/E ratio is negative, making its value useless in the assessment of premium or discount valuation, only displaying that the company has negative earnings per share. Conducting a second comparison, its price-to-book ratio of 3.03 indicates a premium versus the S&P 500 average of 2.67 and a significant discount versus the industry average of 6.54. The current price-to-sales ratio is well above the S&P 500 average, but below the industry average. After reviewing these and other key valuation criteria, ZOGENIX INC proves to trade at a discount to investment alternatives within the industry.
|ZGNX NM||Peers 34.36||ZGNX NM||Peers 21.51|
Neutral. The absence of a valid P/E ratio happens when a stock can not be valued on the basis of a negative stream of earnings.
ZGNX's P/E is negative making this valuation measure meaningless.
Neutral. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.
ZGNX's P/CF is negative making the measure meaningless.
|ZGNX NM||Peers 17.44||ZGNX NA||Peers 0.89|
Neutral. The absence of a valid price-to-projected earnings ratio happens when a stock can not be valued on the basis of a negative expected future earnings.
ZGNX's ratio is negative making this valuation measure meaningless.
Neutral. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.
Ratio not available.
|ZGNX 3.03||Peers 6.54||ZGNX -525.00||Peers -110.09|
Discount. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.
ZGNX is trading at a significant discount to its peers.
Lower. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.
However, ZGNX is expected to significantly trail its peers on the basis of its earnings growth rate.
|ZGNX 9.17||Peers 9.35||ZGNX 14.29||Peers 9.70|
Average. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.
ZGNX is trading at a valuation on par with its industry on this measurement.
Higher. A sales growth rate that exceeds the industry implies that a company is gaining market share.
ZGNX has a sales growth rate that significantly exceeds its peers.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV